ARID1A and gastric cancer: In addition, treatment of gastric cancer cell lines with the methyltransferase inhibitor 5-aza-2’-deoxycytidine increased ARID1A expression, which indicated the important role of DNA hypermethylation in ARID1A downregulation (32).